MDXH
MDxHealth S.A.
There isn't enough reported data to score MDXH yet.
MDXH Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Unavailable |
MDXH's profitability is currently under pressure. There isn't enough data to rate its revenue, cash flow and balance sheet.
MDXH PE Valuation
MDXH has no meaningful PE right now: it lost money over the past year.
MDXH Forward outlook
There aren't enough analyst estimates for MDXH to show an outlook.
MDXH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2025 | -$0.67 | +$0.49 |
| Q4 2024 | -$1.16 | +$0.50 |
| Q4 2023 | -$1.66 | +$1.14 |
MDXH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2025 | $107.9M | +20% |
| Q4 2024 | $90M | +28% |
| Q4 2023 | $70.2M | +89% |
| Q4 2022 | $37.1M | +67% |
| Q4 2021 | $22.2M | +159% |
| Q4 2020 | $8.6M | +841% |
| Q2 2020 | $9.9M | -9.1% |
| Q4 2019 | $912K | -92% |
MDXH's revenue has grown year over year for five quarters in a row: $108M last quarter, up 385% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | -13% | +107 points |
| Q4 2024 | -27% | +137 points |
| Q4 2023 | -39% | +93 points |
| Q4 2022 | -102% | +2766 points |
| Q4 2021 | -121% | +6.8 points |
| Q4 2020 | -165% | -12 points |
| Q2 2020 | -131% | -45 points |
| Q4 2019 | -2868% | -2790 points |
MDXH's operating margin was −13% last quarter, up 107 points from the same quarter a year ago, near the top of its range since 2009.
MDXH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | -$3.3M | +$16.4M |
| Q4 2024 | -$19.7M | +$4.5M |
| Q4 2023 | -$24.2M | +$12.7M |
| Q4 2022 | -$36.9M | -$13.5M |
| Q4 2021 | -$23.4M | -$14.1M |
| Q4 2020 | -$9.4M | -$863K |
| Q2 2020 | -$11.4M | +$2.4M |
| Q4 2019 | -$8.5M | -$1.7M |
MDXH has burned cash in almost every quarter: −$84M over the past year, against −$53M the year before.
MDXH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +52% | +17.1M shares |
| 1 year | +454% | +40.9M shares |
| 3 years | +966% | +45.3M shares |
| 5 years | +2164% | +47.8M shares |
| Available history | +3691% | +48.6M shares |
MDXH has 50M diluted shares, up 454% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q2 2020 | — |
| Q4 2019 | — |
| Q2 2019 | — |
| Q4 2018 | — |
| Q2 2018 | — |
| Q4 2017 | — |
| Q2 2017 | — |
MDXH Net Leverage
MDXH's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
MDXH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 24.4 | Oversold |
| Stochastic | 0.7 | Oversold |
MDXH's weekly RSI is 24 (oversold) and its Stochastic is 1 (oversold).
MDXH PE vs Healthcare Sector
MDXH has no meaningful PE right now: it lost money over the past year.
MDXH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.32 | 56% below |
| 20 week MA | $0.48 | 71% below |
| 50 week MA | $1.68 | 92% below |
| 100 week MA | $2.14 | 93% below |
MDXH is in a downtrend: it's below all four of its weekly moving averages, and 93% below its 100-week average.
MDXH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2023 | $3.07 | $3.94 | +28% |
| 2024 | $3.94 | $2.31 | -41% |
| 2025 | $2.31 | $3.41 | +48% |
| 2026 YTD | $3.41 | $0.14 | -96% |
MDXH is down 96% so far in 2026, after finishing higher in two of the previous three years.